Accuray (ARAY) Other financing activities (2011 - 2026)
Accuray's (ARAY) quarterly Other financing activities came in at $512000.0 in Q1 2026, up 195.95% year-on-year from $173000.0 in Q1 2025, and up 36.53% quarter-over-quarter from $375000.0 in Q4 2025.
Accuray (ARAY) Other financing activities (2011 - 2026) Analysis & Trends
Accuray's Other financing activities history runs 16 years deep, the most recent figure standing at $512000.0 for Q1 2026.
- On a quarterly basis, Other financing activities rose 195.95% year-over-year to $512000.0 in Q1 2026; TTM through Mar 2026 was $1.1 million, a 28.62% decrease from a year earlier, with the FY2025 full-year figure at $13.3 million, up 16306.17% from the prior year.
- Other financing activities climbed to $512000.0 in Q1 2026 per ARAY's latest filing, from $375000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $1.2 million in Q1 2022 and bottomed at $173000.0 in Q3 2024.
- The 5-year median for Other financing activities is $443500.0 (2025), against an average of $599333.3.
- Across the five-year window, Other financing activities decreased 6.94% in 2023 and surged 195.95% in 2026, its largest moves.
- Year by year, Other financing activities stood at $1.2 million in 2022, then fell by 6.94% to $1.1 million in 2023, then sank by 84.81% to $173000.0 in 2024, then soared by 116.76% to $375000.0 in 2025, then surged by 36.53% to $512000.0 in 2026.
- Per Business Quant, the three latest ARAY Other financing activities figures stand at $512000.0 (Q1 2026), $375000.0 (Q4 2025), and $173000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.39 Bn | 175.10 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.87 Bn | 3.81 Bn |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.22 Bn | 66.77 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn |
| 6 | Dexcom | 28.58 Bn | 27.46 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.48 Bn | 26.20 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn |
| 10 | Accuray | 29,099.57 | -38.50 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 512,000.00 |
| Mar 31, 2026 | 512,000.00 |
| Dec 31, 2025 | 375,000.00 |
| Dec 31, 2025 | 375,000.00 |
| Mar 31, 2025 | 173,000.00 |
| Mar 31, 2025 | 173,000.00 |
| Sep 30, 2024 | 173,000.00 |
| Sep 30, 2024 | 173,000.00 |
| Mar 31, 2023 | 1.14 Mn |
| Mar 31, 2023 | 1.14 Mn |
| Mar 31, 2022 | 1.22 Mn |
| Mar 31, 2022 | 1.22 Mn |
| Mar 31, 2021 | 855,000.00 |
| Mar 31, 2021 | 855,000.00 |
| Jun 30, 2020 | 1.09 Mn |
| Jun 30, 2020 | 1.09 Mn |
| Mar 31, 2020 | 1,000.00 |
| Mar 31, 2020 | 1,000.00 |
| Dec 31, 2019 | 1.36 Mn |
| Dec 31, 2019 | 1.36 Mn |